Sustained unemployment in psychiatric outpatients with bipolar disorder: frequency and association with demographic variables and comorbid disorders

Zimmerman, Mark; Galione, Janine N.; Chelminski, Iwona; Young, Diane; Dalrymple, Kristy; Ruggero, Camilo J.

doi:10.1111/j.1399-5618.2010.00869.x

Cited by 59 publications

(38 citation statements)

References 29 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Regarding other comorbidities, Dickerson et al (24) found substance abuse as a predictor of absenteeism. In the Zimmerman et al study (40), patients who were unemployed during more than 2 years of the prior 5 years experienced more current panic disorder and lifetime history of alcohol abuse or dependence than patients who had not been unemployed during this time. These comorbidities were not associated with receiving SDB in our study.…”

Section: Discussionmentioning

confidence: 94%

See 1 more Smart Citation

Occupational disability in bipolar disorder: analysis of predictors of being on severe disablement benefit (PREBIS study data)

Grande

Goikolea

Dios

et al. 2012

Acta Psychiatr Scand

View full text Add to dashboard Cite

Grande I, Goikolea JM, de Dios C, González‐Pinto A, Montes JM, Saiz‐Ruiz J, Prieto E, Vieta E, for the PREBIS group. Occupational disability in bipolar disorder: analysis of predictors of being on severe disablement benefit PREBIS study data).Objective: Patients diagnosed with bipolar disorder (BD) are reported to have significant work impairment during interepisode intervals. This study was carried out to assess potential predictors of occupational disability in a longitudinal follow‐up of euthymic patients.Method: We included 327 euthymic patients diagnosed with BD type I or type II, 226 of whom were employed and 101 were receiving a severe disablement benefit (SDB). Sociodemographic data were studied and episode recurrence was assessed along a 1‐year follow‐up. Logistic regression analysis was applied to determine predictors of receiving SDB. Cox regression was built to study recurrences.Results: Predictors of receiving SDB were: axis II comorbidity [Odds Ratio (OR) = 2.94, CI: 1.26–6.86, P = 0.013], number of manic episodes (OR = 1.21, CI: 1.10–1.34, P < 0.001), being without stable partner (OR = 2.44, CI: 1.34–4.44, P = 0.004) and older age (OR = 1.08, CI: 1.05–1.12, P < 0.001). Bipolar patients receiving SDB presented more episodic recurrences regardless of polarity than employed bipolar patients (P = 0.002). The time until recurrence in 25% of the bipolar patients receiving SDB was 6.08 months (CI: 4.44–11.77) being 13.08 months (CI: 9.60 to –) in the employed group.Conclusion: Occupational disability in bipolar patients is associated with axis II comorbidity, more previous manic episodes, not having a stable relationship, older age, and more recurrences at 1‐year follow‐up.

show abstract

Section: Discussionmentioning

confidence: 94%

“…Therefore, we expected comorbidity to be associated with poorer functioning and, in particular, with lower occupational functioning (28,40). Axis II disorders were the only comorbidities found to be related to receiving SDB in both unadjusted as well as in adjusted results.…”

Section: Discussionmentioning

confidence: 99%

Occupational disability in bipolar disorder: analysis of predictors of being on severe disablement benefit (PREBIS study data)

Grande

Goikolea

Dios

et al. 2012

Acta Psychiatr Scand

View full text Add to dashboard Cite

show abstract

“…A functional assessment of patients (n = 206) with BD I or BD II noted that more than one-third had missed ‡ 2 years of work time over a five-year period, and extended unemployment was associated with increased rates of panic disorder and alcohol abuse (306). The presence of comorbid panic disorder in patients with BD I (compared to those with no panic disorder) was associated with significantly more depressive, manic, and any mood episodes, as well as increased risk of lifetime SUD or eating disorders (307).…”

Section: Prevalence and Impactmentioning

confidence: 99%

Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013

et al. 2012

View full text Add to dashboard Cite

Yatham LN, Kennedy SH, Parikh SV, Schaffer A, Beaulieu S, Alda M, O’Donovan C, MacQueen G, McIntyre RS, Sharma V, Ravindran A, Young LT, Milev R, Bond DJ, Frey BN, Goldstein BI, Lafer B, Birmaher B, Ha K, Nolen WA, Berk M.  Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013.  Bipolar Disord 2012: 00: 000–000. © 2012 John Wiley & Sons A/S.Published by Blackwell Publishing Ltd.The Canadian Network for Mood and Anxiety Treatments published guidelines for the management of bipolar disorder in 2005, with updates in 2007 and 2009. This third update, in conjunction with the International Society for Bipolar Disorders, reviews new evidence and is designed to be used in conjunction with the previous publications.The recommendations for the management of acute mania remain largely unchanged. Lithium, valproate, and several atypical antipsychotic agents continue to be first‐line treatments for acute mania. Monotherapy with asenapine, paliperidone extended release (ER), and divalproex ER, as well as adjunctive asenapine, have been added as first‐line options.For the management of bipolar depression, lithium, lamotrigine, and quetiapine monotherapy, as well as olanzapine plus selective serotonin reuptake inhibitor (SSRI), and lithium or divalproex plus SSRI/bupropion remain first‐line options. Lurasidone monotherapy and the combination of lurasidone or lamotrigine plus lithium or divalproex have been added as a second‐line options. Ziprasidone alone or as adjunctive therapy, and adjunctive levetiracetam have been added as not‐recommended options for the treatment of bipolar depression. Lithium, lamotrigine, valproate, olanzapine, quetiapine, aripiprazole, risperidone long‐acting injection, and adjunctive ziprasidone continue to be first‐line options for maintenance treatment of bipolar disorder. Asenapine alone or as adjunctive therapy have been added as third‐line options.

show abstract

“…Beyond the challenges to social adjustment, limited occupational functioning is also widespread in BD, including during euthymia Burdick et al, 2010;Dickerson et al, 2010;Zimmerman et al, 2010). Despite studies reporting people with BD to have more years of college and more B.A.…”

Section: Functional Impairment In Bdmentioning

confidence: 99%

Psychosocial Functioning in Bipolar Disorder from a Social Justice Perspective

Manove¹,

Price²,

Levy³

2012

Bipolar Disorder - A Portrait of a Complex Mood Disorder

View full text Add to dashboard Cite

Sustained unemployment in psychiatric outpatients with bipolar disorder: frequency and association with demographic variables and comorbid disorders

Cited by 59 publications

References 29 publications

Occupational disability in bipolar disorder: analysis of predictors of being on severe disablement benefit (PREBIS study data)

Occupational disability in bipolar disorder: analysis of predictors of being on severe disablement benefit (PREBIS study data)

Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013

Psychosocial Functioning in Bipolar Disorder from a Social Justice Perspective

Contact Info

Product

Resources

About